X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50412) 50412
Newsletter (893) 893
Magazine Article (223) 223
Book Chapter (114) 114
Book / eBook (48) 48
Newspaper Article (47) 47
Dissertation (42) 42
Conference Proceeding (28) 28
Publication (24) 24
Book Review (13) 13
Web Resource (8) 8
Reference (5) 5
Journal / eJournal (3) 3
Government Document (2) 2
Streaming Video (2) 2
Microfilm (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29257) 29257
male (25558) 25558
animals (20640) 20640
vasodilator agents - pharmacology (18917) 18917
female (16877) 16877
vasodilator agents - therapeutic use (13432) 13432
middle aged (11249) 11249
rats (9349) 9349
adult (8776) 8776
cardiac & cardiovascular systems (7967) 7967
aged (7815) 7815
vasodilator agents - administration & dosage (7330) 7330
vasodilators (6792) 6792
pharmacology & pharmacy (6588) 6588
vasodilation - drug effects (5029) 5029
dose-response relationship, drug (4999) 4999
nitric oxide (4994) 4994
in vitro techniques (4899) 4899
blood pressure - drug effects (4731) 4731
vasodilator agents (4180) 4180
peripheral vascular disease (4024) 4024
nitric-oxide (3773) 3773
treatment outcome (3614) 3614
hypertension (3492) 3492
endothelium (3468) 3468
time factors (3421) 3421
dogs (3309) 3309
hemodynamics - drug effects (3261) 3261
acetylcholine - pharmacology (3255) 3255
physiology (3167) 3167
rats, sprague-dawley (2960) 2960
endothelium, vascular - drug effects (2920) 2920
rats, wistar (2894) 2894
vasodilation (2581) 2581
nitroprusside - pharmacology (2576) 2576
vasoconstrictor agents - pharmacology (2555) 2555
vasodilator agents - adverse effects (2555) 2555
muscle, smooth, vascular - drug effects (2516) 2516
blood vessels (2408) 2408
research (2343) 2343
surgery (2270) 2270
nitric oxide - metabolism (2253) 2253
dilatation (2244) 2244
rabbits (2243) 2243
heart rate - drug effects (2227) 2227
mice (2225) 2225
blood pressure (2207) 2207
heart failure - drug therapy (2172) 2172
analysis (1963) 1963
acetylcholine (1960) 1960
enzyme inhibitors - pharmacology (1925) 1925
vascular resistance - drug effects (1904) 1904
vasodilation - physiology (1850) 1850
risk factors (1794) 1794
vasoconstriction - drug effects (1775) 1775
blood-flow (1755) 1755
hemodynamics (1755) 1755
hypertension, pulmonary - drug therapy (1740) 1740
disease models, animal (1731) 1731
vasodilator (1730) 1730
coronary vessels - drug effects (1723) 1723
drug therapy, combination (1714) 1714
prospective studies (1696) 1696
physiological aspects (1694) 1694
regional blood flow - drug effects (1694) 1694
nitroglycerin - pharmacology (1682) 1682
double-blind method (1626) 1626
care and treatment (1624) 1624
endothelium, vascular - physiopathology (1620) 1620
hypertension - drug therapy (1614) 1614
medicine, general & internal (1612) 1612
smooth-muscle (1606) 1606
endothelium, vascular - physiology (1577) 1577
pulmonary hypertension (1577) 1577
sildenafil citrate (1563) 1563
nitroglycerin (1546) 1546
biochemistry & molecular biology (1541) 1541
coronary circulation - drug effects (1540) 1540
adenosine (1533) 1533
medicine & public health (1498) 1498
adolescent (1478) 1478
inhibition (1461) 1461
cardiology (1438) 1438
heart failure (1435) 1435
arteries (1434) 1434
respiratory system (1433) 1433
ischemia (1424) 1424
heart (1422) 1422
therapy (1422) 1422
hypertension - physiopathology (1407) 1407
electrocardiography (1406) 1406
nitric-oxide synthase (1393) 1393
rat (1380) 1380
neurosciences (1363) 1363
aged, 80 and over (1362) 1362
prognosis (1340) 1340
drug therapy (1336) 1336
cells (1329) 1329
cells, cultured (1327) 1327
disease (1315) 1315
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (37) 37
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Periodical Stacks (1) 1
Media Commons - Microtexts (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46434) 46434
French (1344) 1344
Russian (1289) 1289
Japanese (1196) 1196
German (783) 783
Chinese (483) 483
Italian (290) 290
Spanish (248) 248
Polish (233) 233
Portuguese (138) 138
Hungarian (100) 100
Czech (80) 80
Dutch (68) 68
Danish (52) 52
Ukrainian (52) 52
Norwegian (32) 32
Turkish (25) 25
Bulgarian (23) 23
Finnish (23) 23
Romanian (23) 23
Croatian (19) 19
Serbian (13) 13
Slovak (13) 13
Korean (12) 12
Lithuanian (10) 10
Swedish (10) 10
Hebrew (8) 8
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nitric oxide, ISSN 1089-8603, 1997
Journal
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2018, Issue 12, p. CD002787
Background Acute hypoxaemic respiratory failure (AHRF) and mostly acute respiratory distress syndrome (ARDS) are critical conditions. AHRF results from several... 
Length of Stay | Respiratory Insufficiency | Acute respiratory distress syndrome | Acute Disease | Costs | Lungs & airways | Respiratory Distress Syndrome, Adult | Administration, Inhalation | Respiratory Management | Post‐anaesthetic unit/intensive care unit | Nitric Oxide | Pain & anaesthesia | Insurance medicine | Randomized Controlled Trials as Topic | Vasodilator Agents | Respiratory distress syndrome | Child health | Hypoxia | Respiratory care | Medicine General & Introductory Medical Sciences | Acute Lung Injury | RANDOMIZED-TRIALS | PEROXYNITRITE | Humans | METAANALYSES | Anoxia [drug therapy; mortality] | ACUTE LUNG INJURY | Respiratory Distress Syndrome, Adult [drug therapy | MEDICINE, GENERAL & INTERNAL | THERAPY | RIGHT-VENTRICULAR FUNCTION | Adult | Child | Nitric Oxide [administration & dosage; adverse effects] | RISK-FACTORS | Vasodilator Agents [adverse effects; therapeutic use] | FAILURE | Respiratory Insufficiency [drug therapy; mortality] | Acute Lung Injury [drug therapy; mortality] | mortality | OUTCOMES | SEQUENTIAL MONITORING BOUNDARIES | Hypoxia - drug therapy | Vasodilator Agents - therapeutic use | Respiratory Insufficiency - mortality | Hypoxia - mortality | Nitric Oxide - adverse effects | Respiratory Distress Syndrome, Adult - mortality | Nitric Oxide - administration & dosage | Respiratory Distress Syndrome, Adult - drug therapy | Acute Lung Injury - mortality | Acute Lung Injury - drug therapy | Vasodilator Agents - adverse effects | Respiratory Insufficiency - drug therapy
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2003, Volume 108, Issue 17, pp. 2066 - 2069
Background - The prognosis and functional capacity of patients with pulmonary arterial hypertension (PAH) is poor, and there is a need for safe, effective,... 
Potassium | Hypertension, pulmonary | Sildenafil | CARDIAC & CARDIOVASCULAR SYSTEMS | potassium | THERAPY | hypertension, pulmonary | PERIPHERAL VASCULAR DISEASE | VASODILATOR | HEMATOLOGY | sildenafil | INHALED NITRIC-OXIDE | Large-Conductance Calcium-Activated Potassium Channels | Piperazines - administration & dosage | Phosphoric Diester Hydrolases - biosynthesis | Liver - enzymology | Vasodilator Agents - therapeutic use | Cyclic Nucleotide Phosphodiesterases, Type 5 | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Piperazines - economics | Male | Time | Sildenafil Citrate | Purines | Liver - drug effects | Exercise Test - drug effects | Vascular Resistance - drug effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Vasodilator Agents - economics | Sulfones | Muscle, Smooth, Vascular - drug effects | Administration, Oral | Cell Separation | Phosphoric Diester Hydrolases - drug effects | Stroke Volume - drug effects | Treatment Outcome | Piperazines - therapeutic use | Pulmonary Artery - physiopathology | Pulmonary Artery - drug effects | Piperazines - adverse effects | Patch-Clamp Techniques | Pilot Projects | Heart Ventricles - physiopathology | Potassium Channels, Calcium-Activated - drug effects | 3',5'-Cyclic-GMP Phosphodiesterases | Creatinine - analysis | Hemodynamics - drug effects | Vasodilator Agents - adverse effects | In Vitro Techniques | Muscle, Smooth, Vascular - enzymology | Vasodilator Agents - administration & dosage | Heart Ventricles - drug effects
Journal Article
Journal Article
Magnetic resonance imaging, ISSN 0730-725X, 04/2013, Volume 31, Issue 3, p. 336
Resting fluctuations in arterial CO.sub.2 (a cerebral vasodilator) are believed to be an important source of low-frequency blood oxygenation level dependent... 
Vasodilators
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 10/2007, Volume 116, Issue 16, pp. 1821 - 1831
Background - The recent discovery that nitrite is an intrinsic vasodilator and signaling molecule at near-physiological concentrations has raised the... 
Hemoglobin | Endothelium-derived factors | Free radicals | Nitric oxide | Nitroglycerin | OXIDE SYNTHASE ACTIVITY | free radicals | nitric oxide | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECTLY ACTING VASODILATOR | SODIUM-NITRITE | REGIONAL BLOOD-FLOW | SIGNALING MOLECULE | hemoglobin | endothelium-derived factors | ISCHEMIA-REPERFUSION INJURY | PLASMA NITRITE | nitroglycerin | IN-VIVO | EMERGING BIOLOGY | PERIPHERAL VASCULAR DISEASE | CIRCULATING NITRITE | Vasodilator Agents - pharmacokinetics | Sodium Nitrite - administration & dosage | Humans | Macaca fascicularis | Endothelium, Vascular - drug effects | Male | Enzyme Inhibitors - administration & dosage | Regional Blood Flow - drug effects | Endocrine System - drug effects | Adult | Female | Xanthine Oxidase - metabolism | Oxidation-Reduction | Drug Tolerance | Hemoglobins - metabolism | Ascorbic Acid - administration & dosage | Oxypurinol - administration & dosage | Vasodilator Agents - blood | Animals | Sodium Nitrite - blood | Endothelium, Vascular - metabolism | Antioxidants - administration & dosage | Vasodilation - drug effects | Nitric Oxide - metabolism | Sodium Nitrite - pharmacokinetics | Vasodilator Agents - administration & dosage | Infusions, Intra-Arterial | Physiological aspects | Vascular endothelium | Dosage and administration | Research | Pharmacokinetics | Nitrites
Journal Article
European journal of nuclear medicine and molecular imaging, ISSN 1619-7089, 2015, Volume 42, Issue 12, pp. 1929 - 1940
Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005,... 
Myocardial perfusion imaging | Medicine & Public Health | Orthopedics | Oncology | Procedures | Nuclear Medicine | Imaging / Radiology | Cardiology | Guidelines | Nuclear medicine | ATTENUATION CORRECTION | ADVERSE-REACTIONS | PROGNOSTIC VALUE | EMISSION COMPUTED-TOMOGRAPHY | DIAGNOSTIC PERFORMANCE | HYBRID PET/CT | A(2A) AGONIST | DOUBLE-BLIND | CONTRAST-MEDIA | TOMOGRAPHY CORONARY-ANGIOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Myocardial Perfusion Imaging - instrumentation | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Dose-Response Relationship, Drug | Multimodal Imaging | Exercise | Societies, Medical | Coronary Artery Disease - physiopathology | Adult | Purines - adverse effects | Safety | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Tomography, X-Ray Computed - instrumentation | Vasodilator Agents - pharmacology | Purines - pharmacology | Myocardial Perfusion Imaging - methods | Radiation Exposure | Coronary Artery Disease - diagnostic imaging | Tomography, X-Ray Computed - adverse effects | Contrast Media | Image Processing, Computer-Assisted | Myocardial Perfusion Imaging - adverse effects | Software | Vasodilator Agents - adverse effects | Practice Guidelines as Topic | Vasodilators | SPECT imaging | Tomography | Medical imaging | Clinical Medicine | Radiologi och bildbehandling | Medical and Health Sciences | Medicin och hälsovetenskap | Radiology, Nuclear Medicine and Medical Imaging | Klinisk medicin
Journal Article
Nitric oxide, ISSN 1089-8603, 04/2013, Volume 31, p. S35
Aging is associated with progressive vascular dysfunction. Cocoa flavanols were shown to improve endothelial vasodilator function and decrease blood... 
Vasodilators
Journal Article
Research Paper - Effect of redox agents on the response of rat aorta to nitric oxide and sodium nitroprusside, 12/2006
Objective: To study the redox regulation of vascular responses to endogenous nitric oxide (NO) and NO derived from nitrovasodilator sodium nitroprusside (SNP)... 
Reducing agents, vasodilators, vitamin C
Journal
Drugs, ISSN 0012-6667, 8/2015, Volume 75, Issue 12, pp. 1349 - 1371
Nebivolol is a highly selective β1-adrenergic receptor antagonist with a pharmacologic profile that differs from those of other drugs in its class. In addition... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | BETA-BLOCKER TREATMENT | ARTERIAL-HYPERTENSION | DOUBLE-BLIND | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | CENTRAL AORTIC PRESSURE | BLOOD-PRESSURE | HYPERTENSIVE PATIENTS | ERECTILE DYSFUNCTION | LEFT-VENTRICULAR FUNCTION | ELDERLY HEART-FAILURE | Drug Costs | Vasodilator Agents - pharmacokinetics | Vasodilator Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hypertension - drug therapy | Nebivolol - economics | Adrenergic beta-1 Receptor Agonists - pharmacokinetics | Nebivolol - pharmacokinetics | Blood Pressure - drug effects | Heart Failure - diagnosis | Vasodilator Agents - economics | Drug Therapy, Combination | Heart Failure - economics | Hypertension - diagnosis | Hypertension - economics | Antihypertensive Agents - economics | Adrenergic beta-1 Receptor Agonists - therapeutic use | Nebivolol - therapeutic use | Treatment Outcome | Antihypertensive Agents - pharmacokinetics | Adrenergic beta-1 Receptor Agonists - economics | Antihypertensive Agents - therapeutic use | Nebivolol - adverse effects | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Heart Failure - drug therapy | Animals | Cost-Benefit Analysis | Adrenergic beta-1 Receptor Agonists - adverse effects | Vasodilator Agents - adverse effects
Journal Article